143 related articles for article (PubMed ID: 37326710)
1. Methods for Analyzing the Gut Microbiota in Diabetic Retinopathy.
Huang Y; Ma JH; Peng Y; Yang X; Chen J; Tang S
Methods Mol Biol; 2023; 2678():147-155. PubMed ID: 37326710
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy.
Huang Y; Wang Z; Ma H; Ji S; Chen Z; Cui Z; Chen J; Tang S
Front Cell Infect Microbiol; 2021; 11():646348. PubMed ID: 33816351
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.
Das T; Jayasudha R; Chakravarthy S; Prashanthi GS; Bhargava A; Tyagi M; Rani PK; Pappuru RR; Sharma S; Shivaji S
Sci Rep; 2021 Feb; 11(1):2738. PubMed ID: 33531650
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome and diabetic retinopathy.
Jabbehdari S; Sallam AB
Eur J Ophthalmol; 2022 Sep; 32(5):2494-2497. PubMed ID: 35266406
[TBL] [Abstract][Full Text] [Related]
5. Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus.
Zhang W; Wang T; Guo R; Cui W; Yu W; Wang Z; Jiang Y; Jiang M; Wang X; Liu C; Xiao J; Shang J; Wen X; Zhao Z
Front Cell Infect Microbiol; 2021; 11():761757. PubMed ID: 35118005
[TBL] [Abstract][Full Text] [Related]
6. Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing.
Shahi SK; Zarei K; Guseva NV; Mangalam AK
J Vis Exp; 2019 Oct; (152):. PubMed ID: 31680682
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation differences of ginsenoside compound K mediated by the gut microbiota from diabetic patients and healthy subjects.
Huang S; Shao L; Chen M; Wang L; Liu J; Zhang W; Huang W
Chin J Nat Med; 2023 Oct; 21(10):723-729. PubMed ID: 37879791
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota dysbiosis in a cohort of patients with psoriasis.
Hidalgo-Cantabrana C; Gómez J; Delgado S; Requena-López S; Queiro-Silva R; Margolles A; Coto E; Sánchez B; Coto-Segura P
Br J Dermatol; 2019 Dec; 181(6):1287-1295. PubMed ID: 30920647
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks.
Wang Y; Luo X; Mao X; Tao Y; Ran X; Zhao H; Xiong J; Li L
PLoS One; 2017; 12(3):e0172774. PubMed ID: 28328990
[TBL] [Abstract][Full Text] [Related]
10. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
11. Impact of DNA extraction, sample dilution, and reagent contamination on 16S rRNA gene sequencing of human feces.
Velásquez-Mejía EP; de la Cuesta-Zuluaga J; Escobar JS
Appl Microbiol Biotechnol; 2018 Jan; 102(1):403-411. PubMed ID: 29079861
[TBL] [Abstract][Full Text] [Related]
12. The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy.
Zhang H; Mo Y
Front Endocrinol (Lausanne); 2023; 14():1205846. PubMed ID: 37469982
[TBL] [Abstract][Full Text] [Related]
13. Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis.
Saralegui C; García-Durán C; Romeu E; Hernáez-Sánchez ML; Maruri A; Bastón-Paz N; Lamas A; Vicente S; Pérez-Ruiz E; Delgado I; Luna-Paredes C; Caballero JD; Zamora J; Monteoliva L; Gil C; Del Campo R
Microbiol Spectr; 2022 Dec; 10(6):e0146622. PubMed ID: 36255300
[TBL] [Abstract][Full Text] [Related]
14. Assessing microbiota composition in the context of aging.
Campos-Iglesias D; Freije JMP; López-Otín C
Methods Cell Biol; 2024; 181():73-85. PubMed ID: 38302245
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal Autonomic Neuropathy Exacerbates Gut Microbiota Dysbiosis in Adult Patients With Type 2 Diabetes Mellitus.
Du Y; Neng Q; Li Y; Kang Y; Guo L; Huang X; Chen M; Yang F; Hong J; Zhou S; Zhao J; Yu F; Su H; Kong X
Front Cell Infect Microbiol; 2021; 11():804733. PubMed ID: 35211420
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies.
Cai Y; Kang Y
Biomed Pharmacother; 2023 Aug; 164():114994. PubMed ID: 37301133
[TBL] [Abstract][Full Text] [Related]
17. Optimisation of 16S rRNA gut microbiota profiling of extremely low birth weight infants.
Alcon-Giner C; Caim S; Mitra S; Ketskemety J; Wegmann U; Wain J; Belteki G; Clarke P; Hall LJ
BMC Genomics; 2017 Nov; 18(1):841. PubMed ID: 29096601
[TBL] [Abstract][Full Text] [Related]
18. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
19. Microbial Signatures in The Rodent Eyes With Retinal Dysfunction and Diabetic Retinopathy.
Prasad R; Asare-Bediko B; Harbour A; Floyd JL; Chakraborty D; Duan Y; Lamendella R; Wright J; Grant MB
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):5. PubMed ID: 34985498
[TBL] [Abstract][Full Text] [Related]
20. Full-length 16S rRNA gene amplicon analysis of human gut microbiota using MinION™ nanopore sequencing confers species-level resolution.
Matsuo Y; Komiya S; Yasumizu Y; Yasuoka Y; Mizushima K; Takagi T; Kryukov K; Fukuda A; Morimoto Y; Naito Y; Okada H; Bono H; Nakagawa S; Hirota K
BMC Microbiol; 2021 Jan; 21(1):35. PubMed ID: 33499799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
